Fulcrum Therapeutics Inc (FULC)

Jul 25, 2025

Fulcrum Therapeutics Inc. Stock Analysis and ForecastGame-changing capital returns - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about Fulcrum Therapeutics Inc. stockFree Investment Portfolio Suggestions - Autocar Professional

Jul 25, 2025

Jul 25, 2025

What makes Fulcrum Therapeutics Inc. stock price move sharplyDefensive Stock Picks with Upside - Newser

Jul 25, 2025

Jul 25, 2025

Why Fulcrum Therapeutics Inc. stock attracts strong analyst attentionMassive Profit Potential - Newser

Jul 25, 2025

Jul 24, 2025

Will Fulcrum Therapeutics Inc. stock benefit from interest rate changesDynamic profit opportunities - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

What drives Fulcrum Therapeutics Inc. stock priceFree Investment Portfolio Suggestions - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is Fulcrum Therapeutics Inc. a good long term investmentHigh-yield growth strategies - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

why fulcrum therapeutics inc. stock attracts strong analyst attentionWeekly Double Return List - Newser

Jul 18, 2025

Jul 15, 2025

How Fulcrum Therapeutics Inc. stock performs during market volatilitySafe High Return Entry Points - Newser

Jul 15, 2025

Jul 11, 2025

Fulcrum Therapeutics (FULC) Drops 2.25% Despite 3.25% Intraday Gain - AInvest

Jul 11, 2025

Jul 11, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jul 11, 2025

Jul 11, 2025

Fulcrum Therapeutics Awards Major Stock Options Package Worth $912,600 to Strategic New Hire - Stock Titan

Jul 11, 2025

Jul 09, 2025

Fulcrum Therapeutics (FULC) Soars 14.31% on Earnings Report - AInvest

Jul 09, 2025

Jun 28, 2025

Fulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years ago - Yahoo Finance

Jun 28, 2025

Jun 27, 2025

Fulcrum Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jun 27, 2025

Jun 25, 2025

Is Fulcrum Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 21, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Fulcrum Therapeutics (FULC) - The Globe and Mail

Jun 21, 2025

Jun 12, 2025

Bank of America Corp DE Has $432,000 Stock Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jun 12, 2025

Jun 12, 2025

Research Analysts Issue Forecasts for FULC FY2026 Earnings - Defense World

Jun 12, 2025

Jun 11, 2025

Citadel Advisors LLC Makes New $69,000 Investment in Lisata Therapeutics, Inc. (NASDAQ:LSTA) - Defense World

Jun 11, 2025

Jun 11, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Acquired by Millennium Management LLC - Defense World

Jun 11, 2025

Jun 10, 2025

Comparing Fulcrum Therapeutics (NASDAQ:FULC) and Lakeshore Biopharma (NASDAQ:LSB) - Defense World

Jun 10, 2025

Jun 08, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Two Sigma Investments LP - Defense World

Jun 08, 2025

Jun 08, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jun 08, 2025